TNF and tuberculosis: Similarly, another study from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis reported a crude IR for OIs (excluding tuberculosis) of 0.13 for all bDMARDs and TNF inhibitors, 0.15 for rituximab and 0.08 for tocilizumab [21].